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Objectives: Inflammasomes are signaling platforms that upon sensing pathogens and sterile 
stressors mediate the release of mature forms of interleukin (IL)-1β and IL-18.  The aims of this 
study were to determine: 1) the expression of major inflammasome components in the 
chorioamniotic membranes in spontaneous labor at term; 2) whether there are changes in the 
inflammasome components associated with activation of caspase-1 and caspase-4; and 3) 
whether these events are associated with the release of the mature forms of IL-1β and IL-18. 
Methods: Chorioamniotic membranes were collected from women at term with and without 
spontaneous labor. mRNA abundance and protein concentrations of inflammasome components, 
nucleotide-binding oligomerization domain-containing (NOD)1 and NOD2 proteins, caspase-1 
and caspase-4, IL-1β, and IL-18 were quantified by qRT-PCR (n=28-29 each), ELISA (n=10 
each) or immunoblotting (n=8 each), and immunohistochemistry (n=10 each). Active caspase-1 
and caspase-4, as well as mature IL-18, were determined by immunoblotting (n=4 each), and 
pro- and mature forms of IL-1β were determined by ELISA (n=4-7 each).  
Results: Inflammasome components and NOD proteins were expressed in the chorioamniotic 
membranes obtained from women at term. The chorioamniotic membranes from women who 
had undergone labor had: 1) higher NLRP3 (NOD-like receptor family, pyrin domain-containing 
protein 3) and NOD1 protein concentrations; 2) greater immunoreactivity for caspase-1 and 
caspase-4; 3) higher quantity of the active form of caspase 1 (p20); and 4) higher mRNA 
abundance and protein concentrations of pro- and mature IL-1β. However, mRNA abundance 
and protein concentrations of the mature form of IL-18 were not increased in tissues from 
women who underwent labor at term.  
Conclusions: Spontaneous labor at term is characterized by the expression of inflammasome 
components , which may participate in the activation of caspase-1 leading to the consequent 
cleavage and release of mature IL-1β by the chorioamniotic membranes. These results support 
the participation of the inflammasome in the mechanisms responsible for spontaneous parturition 
at term.  
Keywords:
INTRODUCTION 
 amnion, caspase-1, caspase-4, chorion, cytokine, labor, IL-1β, IL-18, NOD1, NOD2, 
normal pregnancy, parturition, sterile inflammation, preterm labor, biomarker, chorioamniotic 
membranes, NLRP1, NLRP3, NLRC4, AIM2 
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Spontaneous term labor is a state of physiologic sterile inflammation.1-6 The evidence in 
support of this concept includes the increased bioavailability of cytokines7-21 and chemokines22-27 
in the amniotic fluid, maternal circulation,28-31 and reproductive tissues.20, 32-46 Moreover, 
parturition is accompanied by an influx of inflammatory cells,  e.g., neutrophils and 
macrophages, into the cervix,39, 47-56 myometrium,49, 57-63 and chorioamniotic membranes.35, 64-67 
T cells are also present in the chorioamniotic membranes.66, 68 The inflammatory response 
associated with normal spontaneous labor is considered sterile since intra-amniotic infection is 
absent in most women.1, 2, 69-72 
The mechanisms responsible for sterile inflammation in parturition have not been 
elucidated, but are thought to involve inflammasomes,73-75 which are high-molecular-weight 
multi-subunit protein complexes found in the cytoplasm capable of inducing an inflammatory 
response through the production of interleukin (IL)-1β and IL-18.76-110 Their basic structure 
consists of: 1) an inflammasome sensor molecule, 2) the adaptor protein ASC (an apoptosis-
associated speck-like protein), and 3) pro-caspase-1(pro-CASP-1).76-110 Once activated, the 
inflammasome complex induces auto-catalytic cleavage of pro-CASP-1 into its mature/active 
form. Caspase-1 (CASP-1) can then cleave pro-IL-1β and pro-IL-18, and the newly described 
pro-IL-33, into the mature, secreted forms of the cytokines.111-124 In addition, CASP-1 is required 
for a specific type of programmed cell death induced by inflammation: pyroptosis.125-127 
Recently, it was demonstrated that CASP-4 expression is required for activation of CASP-1 in 
ultraviolet B-irradiated keratinocytes and activated macrophages,128 suggesting that caspase-4 
acts upstream of caspase-1 and the inflammasome.129 
Several inflammasomes have been identified and named after their respective pattern 
recognition receptors (PRRs):130 NLR family pyrin domain (NLRP)1,76 NLRP3,131 NLR family 
caspase activation and recruitment domain (CARD) (NLRC)4 (also known as IPAF),132, 133 
interferon gamma-inducible protein 16 (IFI16),134 or absent in melanoma (AIM2).135-143 
Inflammasome specificity depends on which ligand(s) the PRR recognizes, and once PRR-ligand 
binding occurs, the inflammasomes oligomerize with other components of the multi-protein 
complexes and become activated.86, 94, 104, 110, 144, 145 Two additional PRRs belonging to the NLR 
family – the nucleotide-binding oligomerization domain-containing proteins 1 and 2 (NOD1 and 
NOD2) – recognize bacterial peptidoglycan segments, but do not recruit inflammasome 
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components.90, 146-153 Instead, the NODs directly activate nuclear factor kappa B (NF-κB) 
proinflammatory signaling, which can induce the expression of pro-IL-1β76, 87, 131, 146, 154-158 and 
pro-IL-18.115 The functional combination of NOD proteins and inflammasome components (e.g., 
NOD2 and NLRP3) improves immune responses in murine dendritic cells.159 Moreover, 
inflammasome activation is associated with an increased production of eicosanoids 
(prostaglandins and leukotrienes), which leads to further inflammation.160 
We proposed that the inflammasome participates in labor at term73, 74 and in pregnancy 
complications.161-171 Indeed, we demonstrated that CASP-1, the predominant inflammasome-
activated caspase,82, 172 is present in the amniotic fluid and that its concentration increases as a 
function of gestational age.75 In addition, we found that amniotic fluid CASP-1 concentration is 
higher in women in spontaneous labor at term than in those without labor.75 This is mirrored by 
increased amniotic fluid IL-1β bioactivity and immunoreactivity in women in spontaneous labor 
at term.8, 9, 36 IL-18 concentration in the amniotic fluid is also higher in term pregnancies than in 
the second trimester.173 Collectively, this evidence supports the hypothesis that inflammasomes 
are involved in the physiologic sterile inflammatory process associated with spontaneous labor at 
term. The aims of this study were to determine whether: 1) inflammasomes are expressed in the 
chorioamniotic membranes from women who underwent spontaneous labor at term; 2) changes 
in inflammasome components are associated with activation of CASP-1 and CASP-4; and 3) 
these events are associated with the release of the mature forms of IL-1β and IL-18. 
 
MATERIALS AND METHODS 
Human subjects, clinical specimens, and definitions 
A case control study was conducted including patients who delivered at term without 
labor (TNL) or at term after labor (TIL). Chorioamniotic membrane samples were collected from 
the Bank of Biological Specimens of the Perinatology Research Branch, NICHD/NIH/DHHS, 
Wayne State University, and The Detroit Medical Center (Detroit, MI, USA). The Institutional 
Review Boards of these institutions approved the collection and use of biological materials for 
research purposes. All participating women provided written informed consent, and samples 
were collected within 30 minutes after delivery. Demographic and clinical characteristics of 
these study groups are represented in Table I. Patients with multiple births or with neonates 
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having congenital or chromosomal abnormalities were excluded. Labor was defined by the 
presence of regular uterine contractions at a frequency of at least two contractions every 10 
minutes with cervical changes resulting in delivery.174 In each case, tissue sections of the 
chorioamniotic membranes were evaluated for acute histologic chorioamnionitis, according to 
published criteria,175, 176 by pathologists who had been blinded to the clinical outcome. Samples 
collected from women with acute histologic chorioamnionitis were excluded from this study. 
 
RNA isolation, cDNA generation, and qRT-PCR analysis 
TRIzol® (Invitrogen™, Life Technologies Corporation, Grand Island, NY, USA) and 
Qiagen RNeasy® Kits (Qiagen, Gaithersburg, MD, USA) were used to extract total RNA from 
snap-frozen chorioamniotic membrane tissues (TNL, n=29, and TIL, n=28). RNA purity and 
concentration were assessed with the NanoDrop® 1000 spectrophotometer (Thermo Scientific, 
Wilmington, DE, USA), and RNA integrity was evaluated with the Bioanalyzer 2100 (Agilent 
Technologies, Wilmington, DE, USA). The SuperScript® III First-Strand Synthesis System 
(Invitrogen) and oligo(dT)20 primers (Invitrogen) were utilized to generate cDNA. Gene 
expression profiling was performed on the BioMark™ System for high-throughput qRT-PCR 
(Fluidigm, San Francisco, CA, USA) and on the ABI 7500 FAST Real-Time PCR System 
(Applied Biosystems®, Life Technologies Corporation, Foster City, CA, USA) with TaqMan® 
gene expression assays (Applied Biosystems) listed in Table II. 
 
Chorioamniotic membrane tissue lysates 
Fragments of snap-frozen chorioamniotic membranes (TNL and TIL; n=10 each) were 
homogenized using a mechanical tissue homogenizer (T-25 Ultra-Turrax®, IKA® Works, Inc., 
Wilmington, NC, USA) in 2ml of 1X PBS containing a complete protease inhibitor cocktail (Cat. 
No. 11697498001; Roche Applied Science, Mannheim, Germany). Tissue lysates were 
centrifuged at 15700 x g for 5 min at 4°C, and the supernatant was collected and stored at -80°C. 
The protein concentration of the lysates was determined using the Quick Start™ Bradford 
Protein Assay Kit (Bio-Rad, Hercules, CA, USA). Triplicate cell lysates were obtained from the 
membranes of each patient. 
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Chorioamniotic membrane tissue supernatants  
Chorioamniotic membrane samples were collected from each group of women (TNL, 
n=7, and TIL, n=4) and processed the same day. Tissue samples were washed with 1X PBS 
(Invitrogen) and cut into 2cm x 2cm pieces. These tissue explants were transferred into 6-well 
tissue culture plates containing 2ml of Dulbecco's Modified Eagle Medium (DMEM) 
(Invitrogen) per well supplemented with 10% Fetal Bovine Serum (FBS) (Invitrogen) and 1% 
Penicillin/Streptomycin (P/S) (Invitrogen). Tissue samples were placed in a humidified 5% CO2
 
 
incubator at 37ºC overnight, and then tissue culture supernatants were collected and stored at -
80°C. Triplicate supernatants were obtained from the membranes of each patient. 
Enzyme-linked immunosorbent assays  
The concentrations of NLRP1, NLRP3, AIM2, NOD2, CASP-1, CASP-4, IL18, pro-IL-
1β, and IL-1β were measured in the chorioamniotic membrane tissue lysates or supernatants 
using specific and sensitive immunoassays (NLRP1, NLRP3, and NOD2 ELISA kits from 
Cusabio, Wuhan, Hubei, P.R. China; AIM2, CASP-1, and CASP-4 ELISA kits from Cloud 
Clone, Houston, TX, USA; pro-IL-1β and IL-1β ELISA kits from R&D Systems, Minneapolis, 
MN, USA; IL-18 ELISA kits from MBL International Corporation, Woburn, MA, USA), 
following the manufacturers’ instructions. Briefly, recombinant human standards and the 
samples were incubated in duplicate wells of the 96-well microplates pre-coated with 
monoclonal antibodies specific for target analytes. During incubation, immobilized antibodies in 
the microplates bound to the target proteins present in the standard and sample groups. After 
washing the unbound substances, enzyme-conjugated antibodies bound to the target analytes 
were added to the wells. After the incubation, assay plates were washed to remove the unbound 
antibodies, followed by the addition of a substrate solution that developed color proportional to 
the amount of target protein bound in the initial step. Finally, the color development was stopped 
by the addition of a sulfuric acid solution, and the microplates were read using a programmable 
spectrophotometer (SpectraMax M5 Multi-Mode Microplate Reader, Molecular Devices, 
Sunnyvale, CA, USA). The sensitivities of the assays were <4.68 pg/mL for NLRP1, <0.039 
ng/mL for NLRP3, <0.056 ng/mL for AIM2, <6.25 pg/mL for NOD2, <0.112 ng/mL for CASP-
1, <0.053 ng/mL for CASP-4, 3.3 pg/mL for pro-IL-1β, <1 pg/mL for mature IL-1β, and <12.5 
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pg/mL for IL-18. The IL-1β ELISA kit measures approximately 10% of the pro-IL-1β. The 
immunoassays for NLRC4 and NOD1 ELISA did not meet our criteria for validation; instead, 
immunoblotting was performed.  
 
Immunohistochemistry 
Samples of chorioamniotic membranes collected from each study group (TNL and TIL; 
n=10 each) were included. Five-μm-thick sections of formalin-fixed, paraffin-embedded 
chorioamniotic membrane tissues were placed on silanized slides. Immunostainings for NLRP1, 
NLRP3, NLRC4, AIM2, NOD1, NOD2, CASP-1, CASP-4, IL-1β, and IL-18 were performed 
using a Leica Bond Max automatic staining system (Leica Microsystems, Wetzlar, Germany), 
and the Bond™ Polymer Refine Detection Kit (Leica Microsystems) was used to detect the 
chromogenic reaction of horseradish peroxidase. Primary antibodies and a description of the 
immunostaining conditions are presented in Table III. Mouse IgG (Invitrogen) and rabbit IgG 
(Invitrogen) were used as negative controls. A PerkinElmer Pannoramic MIDI slide scanner 
(PerkinElmer, Waltham, MA, USA) was used to assess the intensity of staining (a semi-
quantitative method of analysis). 
 
Chorioamniotic membrane tissue extracts 
Chorioamniotic membrane samples from the two study groups (TNL and TIL; n=4 each) 
were collected and processed on the same day. Ten or 12 tissue explants were obtained from 
each membrane using a dermatological punch (12mm Acu-Punch, Acuderm Inc., Fort 
Lauderdale, FL, USA). Tissue explants were placed at 37ºC in a humidified 5% CO2
 
 incubator 
for 24h in 500μL of DMEM (4.5 g/L glucose, L-glutamine, sodium pyruvate, and 1% antibiotics; 
Gibco®, Life Technologies) in a 24-well plate. Following incubation, tissue explants were 
homogenized in their conditioned medium using a mechanical tissue homogenizer (T-25 Ultra-
Turrax, IKA Works, Inc.). Tissue extracts were centrifuged at 14,000 g for 3-5 min at 4°C, and 
the supernatant was collected and filtered using a syringe filter (Millex-GV Syringe Filter Unit, 
0.22µm, PVDF, 33mm, gamma-sterilized, EMD Millipore, Billerica, MA, USA). Tissue extracts 
were stored at -80°C until use.  
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Immunoblotting 
Chorioamniotic membrane tissue extracts (40µg for the caspases and 100µg for IL-18 per 
well) or tissue lysates (20μg for NOD1 and NLRC4 per well) were subjected to 4-12% SDS-
polyacrylamide gel electrophoresis (Invitrogen). After electrophoresis,  separated proteins were 
transferred onto nitrocellulose membranes (Bio-Rad), and the membranes were blocked with 5% 
non-fat dry milk in Tris-buffered saline containing 0.1% Tween-20 (BioRad) and probed 
overnight at 4°C with specific human antibodies (mouse anti-CASP-1 monoclonal antibody 
[R&D Systems], rabbit anti-CASP-4 polyclonal antibody [Abcam, Cambridge, MA, USA], 
rabbit anti-IL-18 polyclonal antibody [Santa Cruz Biotechnology, Dallas, TX, USA], rabbit anti-
NOD1 polyclonal antibody [Enzo Life Sciences, Farmingdale, NY, USA],165 or mouse anti-
NLRC4 (IPAF) antibody [BioLegend, San Diego, CA, USA]). Nitrocellulose membranes were 
then stripped with Restore™ Plus Western Blot Stripping Buffer (Pierce Biotechnology, Thermo 
Fisher Scientific Inc., Rockford, IL, USA) for 15 min, washed with PBS, blocked, and probed for 
1h at room temperature with a mouse anti-GAPDH monoclonal antibody (Santa Cruz 
Biotechnology) or a mouse anti-ACTB monoclonal antibody (Sigma-Aldrich Co., Saint Louis, 
MO, USA). A horseradish peroxidase-conjugated anti-mouse or anti-rabbit IgG (Cell Signaling, 
Boston, MA, USA) was used as a secondary antibody. Signals were detected by 
chemiluminescence with ChemiGlow West Reagents (Protein Simple, Santa Clara, CA, USA). 
Images were acquired using the FUJIFILM LAS-4000 Imaging System (FUJIFILM North 
America Corporation, Valhalla, NY, USA).   
 
Statistical analyses 
Demographic and clinical data were analyzed using SPSS v.19.0 (SPSS Inc., Chicago, IL, 
USA). Comparisons among the groups were performed using the Chi-square and Fisher’s exact 
tests for proportions, as well as the Mann-Whitney U-test for non-normally distributed 
continuous variables. All other data were analyzed in the R statistical language and environment 
(www.r-project.org). The qRT-PCR dataset, gene expressions relative to ACTB/GAPDH/RPLP0 
were calculated, and the fold-changes between the groups were estimated using a linear model in 
which the -∆Ct value of a gene (surrogate for log2 gene expression) was the dependent variable 
and the group was the independent variable. ELISA, IHC, and immunoblotting data were 
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analyzed using linear models in which the protein concentration or intensity was the dependent 
variable. A fold-change of expression >1.5 and a P value of <0.05 were regarded as statistically 
significant.  
 
RESULTS 
NLRP3 and NOD2 concentrations
We first investigated whether major inflammasome components (NLRP1, NLRP3, 
NLRC4, and AIM2), and NOD proteins (NOD1 and NOD2) were expressed by the 
chorioamniotic membranes from women who had undergone spontaneous labor at term. All 
genes encoding for these proteins were expressed at a detectable level in the chorioamniotic 
membranes from women with or without spontaneous labor at term. However, no differences 
were observed in the expression of the evaluated genes, except NOD1, between these two groups 
of women (Figure 1A,Figures 2A and 2D).  
 increase in the chorioamniotic membranes in 
spontaneous labor at term  
NLRP3 and NOD2 concentrations were higher in the chorioamniotic membrane tissue 
lysates from women who underwent spontaneous labor at term than in those without labor 
(Figure 1B). However, no differences between these two groups of women were observed in the 
protein concentrations of the other evaluated NLRs (Figure 1B, Figures 2B and 2E). 
Immunostaining on formalin-fixed, paraffin-embedded tissue sections collected from the same 
samples showed that all these proteins are expressed in the chorioamniotic membranes. In 
general, most of the proteins showed immunoreactivity in the chorionic trophoblast cells as well 
as in the decidual stromal cells, while some showed weak immunoreactivity in the amniotic 
mesodermal and epithelial cells (Figure 1C, Figures 2C and 2F). 
Collectively, these results suggest that inflammasomes may participate in the physiologic 
sterile inflammatory process of spontaneous parturition at term.  Additionally, the constitutive 
expression of the investigated inflammasome components and NOD proteins in the 
chorioamniotic membranes suggests that inflammasomes may participate in pathological innate 
immune activation leading to preterm labor and term labor in the setting of intra-amniotic 
infection or sterile intra-amniotic inflammation.   
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Activation of CASP-1 in the chorioamniotic membranes in spontaneous labor at term 
Activation of the inflammasome leads to the activation of the inflammatory caspases, i.e., 
CASP-1 and CASP-4.76, 110, 128, 177, 178 We previously demonstrated that amniotic fluid 
concentration of CASP-1 is higher in  women in spontaneous labor at term than in those wihout 
labor at term.75 Therefore, we investigated whether the higher NLRP3 and NOD2 concentrations 
were associated with the activation of CASP-1 and CASP-4 in the chorioamniotic membranes in 
spontaneous labor at term. Genes encoding for CASP-1 and CASP-4 were expressed at detectable 
levels in the chorioamniotic membranes from women with or without spontaneous labor at term; 
however, the mRNA abundance and protein concentration were not significantly different 
between these two groups (Figures 3A and 3B). Semi-quantitative analysis of immunostaining 
indicated that the intensity of both CASP-1 and CASP-4 was higher in the chorioamniotic 
membranes from women who underwent spontaneous labor at term than in those without labor 
(Figure 3C). We also found that the immunoreactivity of the active form of CASP-1 (p20) was 
greater in the chorioamniotic membranes from women who underwent spontaneous labor at term 
than in women who did not undergo labor. The active form of CASP-4 was undetectable by 
immunoblotting (Figure 3D). These data suggest that spontaneous labor at term involves the 
participation of inflammasomes which, in turn, could activate CASP-1 in the chorioamniotic 
membranes.   
 
Increased mRNA abundance and protein concentration of IL-1β in the chorioamniotic 
membranes in spontaneous labor at term  
Activated CASP-1 subunits (p10 and p20) are able to convert inactive pro-IL-1β into its 
bioactive and secreted form.112-114 We previously reported that the IL-1β concentration in 
amniotic fluid (and IL-1 bioactivity) was higher among women in labor than in those wihout 
labor.7-9 Therefore, we investigated whether the activation of CASP-1 was associated with the 
release of mature IL-1β in the chorioamniotic membranes in women who underwent spontaneous 
labor at term. mRNA abundance of IL1B in the chorioamniotic membranes was higher in women 
who had undergone spontaneous labor at term than in those from women without labor (Figure 
4A). The concentrations of mature IL-1β and its pro-form were also higher in the chorioamniotic 
membranes from women who underwent labor than in those from women without labor (Figure 
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4B). IL-1β immunoreactivity appeared to be greater in the chorioamniotic membranes from 
women with labor than in those without labor (Figure 4C). These data suggest that the active 
forms of CASP-1 may participate in the release of the mature form of IL-1β by the 
chorioamniotic membranes in spontaneous labor at term.   
 
IL-18 expression does not increase in the chorioamniotic membranes in spontaneous labor 
at term 
Activated CASP-1 subunits (p10 and p20) are also able to convert inactive pro-IL-18 into 
its bioactive and secreted form.115 We previously demonstrated that during term pregnancies the 
IL-18 amniotic fluid concentration tends to be higher in women who undergo spontaneous labor 
than in women without labor; yet, this increase was not statistically significant.173 We therefore 
investigated whether activation of CASP-1 was associated with the release of mature IL-18 in the 
chorioamniotic membranes of women who underwent  spontaneous labor at term. Consistent 
with our published findings,173 we found that the mRNA abundance and protein concentration of 
IL-18 in the chorioamniotic membranes were not different between women with and without 
spontaneous labor at term (Figure 5A-C). Indeed, mRNA expression of IL-18 was lower in the 
chorioamniotic membranes from women who underwent labor at term than in those without 
labor (Figure 5A). No differences were observed in the abundance of the mature form of IL-18 in 
the chorioamniotic membranes between women with and without spontaneous labor at term 
(Figure 5D). These data suggest that IL-18 does not participate in the physiologic sterile 
inflammatory process of spontaneous parturition at term. 
 
DISCUSSION 
Principal findings of the study: 1) Inflammasome components and NOD proteins were 
expressed in the chorioamniotic membranes from women with normal term pregnancies; 2) 
NLRP3 and NOD2 protein concentrations were greater in the chorioamniotic membrane tissue 
lysates from women who underwent labor at term than in those from women who did not 
undergo labor; 3) the immunoreactivity of CASP-1 and CASP-4 in the chorioamniotic 
membranes was higher among women in labor at term than in those without labor; 4) the active 
form of CASP-1 (p20) was higher in the chorioamniotic membranes from women in labor at 
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term than in women without labor; 5) mRNA abundance and protein expression profiles of IL-1β 
were greater in the chorioamniotic membranes from women in spontaneous labor at term than in 
those without labor; and 6) mRNA abundance and protein expression profiles of IL-18 did not 
increase in the chorioamniotic membranes from women who underwent spontaneous labor at 
term. Collectively, these data support a role for the inflammasome (NLRP1, NLRP3, AIM2 or 
NLRC4) in the activation of CASP-1 and the consequent release of mature IL-1β by the 
chorioamniotic membranes of patients who underwent spontaneous labor at term.  
 
The expression of inflammasome components and NOD proteins in the chorioamniotic 
membranes at term 
We first demonstrated that inflammasome components NLRP1, NLRP3, NLRC4, and 
AIM2, as well as NOD1 and NOD2 proteins, were expressed at the mRNA and protein levels by 
the chorioamniotic membranes from women at term. This is consistent with previous studies 
showing that the human placenta constitutively expresses inflammasome components including 
NOD1, NOD2, NOD3, NOD4, NALP1, NALP2, NALP4, NALP7, NALP10, NALP12, and 
NAIP, as well as CASP-1, CASP-4, and CASP-5,179 and that the chorioamniotic membranes 
express NOD1, NOD2, NLRP1, NLRP3, and ASC.165 
 
The expression of inflammasome 
components and inflammatory caspases in the chorioamniotic membranes may be an important 
feature of innate immune mechanisms at the maternal-fetal interface, which will ensure the rapid 
activation of an immune response when exogenous and/or endogenous signal(s) are recognized.  
Increased concentrations of NLRP3 and NOD2 in the chorioamniotic membranes in 
spontaneous labor at term 
A role for the inflammasomein the physiological proinflammatory processes of 
spontaneous labor at term was initially suggested by our group.73, 75 Herein, we provide evidence 
to support this hypothesis, and demonstrate for the first time that NLRP3 (also known as 
cryopyrin), the PRR component of the NLRP3 inflammasome, is increased in the chorioamniotic 
membranes during spontaneous labor at term. Besides cryopyrin, the NLRP3 inflammasome 
contains the adaptor molecule ASC containing two death-fold domains, one pyrin domain and 
one CARD, and pro-caspase-1.104, 131, 180, 181 Activation of the NLRP3 inflammasome can be 
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triggered by several stimuli,182-188 chemically and structurally different, including crystalline 
material,184, 189 extracellular ATP released from dying cells,190 peptide aggregates such as 
vaccine adjuvant,191-195 phospholipid cardiolipin and mitochondrial DNA,196-198 bacterial toxins 
190, 199, 200
 [i.e., nigericin (Streptomyces hygroscopicus), listeriolysin O (Listeria 
monoccytogenes), aerolysin (Aeromonas), β-and-γ hemolysins (Staphylococcus aureus)], 
DAMPs (damage-associated molecular patterns),186, 187 and PAMPs (pathogen-associated 
molecular patterns) 80, 201-211. Activation of the NLRP3 inflammasome requires two steps: 
priming and assembly of the inflammasome complex.212, 213 The priming step is initiated by 
PRRs, cytokine receptors, or any other factor able to induce activation of NF-κB, which results 
in the up-regulation of NLRP3 to a functional level and pro-IL-1β expression.212-214 The second 
step is post-transcriptional and allows the assembly of the NLRP3 inflammasome complex.212, 213  
Taken together, these data suggest that during spontaneous labor at term the chorioamniotic 
membranes increase the production of NLRP3 as an initial step for inflammasome activation. 
Whether there is assembly of the NLRP3 inflammasome complex in the chorioamniotic 
membranes during spontaneous labor at term requires further investigation.  
We also found that the chorioamniotic membranes from women who underwent 
spontaneous labor had greater concentrations of NOD2 than those from women without labor, 
and such an increase was not associated with an up-regulation of NOD2. Recently, it was 
demonstrated that the mRNA expression of NOD1 and NOD2 in the myometrium is higher in 
women at term with labor than in those at term without labor.215 NOD2 is an intracellular 
receptor that recognizes bacterial muramyl dipeptide (MDP) and activates NF-κB and MAPK 
pathways.216, 217 In dendritic cells, NOD2 can act synergistically with the NLRP3 inflammasome 
in response to MDP and uric acid.159 These results led us to suggest that the chorioamniotic 
membranes overproduce NOD2 protein which, in turn, could synergistically participate with the 
NLRP3 inflammasome in the physiological proinflammatory processes of spontaneous labor at 
term. 
 
Activation of CASP-1, but not CASP-4, in the chorioamniotic membranes in spontaneous 
labor at term 
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Oligomerization of the inflammasome leads to the recruitment of ASC, which binds and 
activates pro-caspase-1 via its CARD.104, 218 We therefore hypothesized that the active forms of 
CASP-1, p10 and p20, would be increased in the chorioamniotic membranes from women who 
underwent spontaneous labor at term. We previously demonstrated that CASP-1 concentration in 
the amniotic fluid from women in spontaneous labor at term is higher than in women wihout 
labor.75 In the current study, we provide evidence to support our initial observation: CASP-1 
immunoreactivity and its active form p20 are increased in the chorioamniotic membranes from 
women who underwent spontaneous labor at term. Recently, it was also found that the mRNA 
expression and active form p10 of CASP-1 are increased in the zone of rupture of the 
chorioamniotic membranes from women who undergo spontaneous labor at term.219 Together, 
these data suggest that during spontaneous labor at term, the chorioamniotic membranes release 
active forms of CASP1. 
Unlike Lappas,219 we did not find differences between the mRNA expression of CASP-1 
in the chorioamniotic membranes from women who underwent labor and non-labor deliveries. 
This discrepancy could be attributed to differences in sampling, number of observations, and 
inclusion of decidua in our experiments. Specifically, we sampled the middle portion of the 
chorioamniotic membranes and did not restrict ourselves to sampling the zone of rupture.66 
Moreover, we utilized full-thickness, unaltered chorioamniotic membranes containing decidua 
parietalis since this type of sample includes immune cells that participate in labor;220, 221 and our 
sample size (n=28-29) was considerably larger than that included in the aforementioned study 
(n=8). 
CASP-11 (human homologue CASP-4) is necessary for the activation of CASP-1, which 
results in the non-canonical NLRP3 inflammasome activation in response to Gram-negative 
bacteria such as Citrobacter rodentium, Escherichia coli, Vibrio cholerae, and Salmonella 
typhimurium.210, 222, 223 Although we found that CASP-4 immunoreactivity was higher in the 
chorioamniotic membranes from women who underwent spontaneous labor at term than in those 
without labor, we did not find the active form of CASP-4 in these tissues. These results 
demonstrate that the activation of CASP-4 is not implicated in the physiological 
proinflammatory processes of spontaneous labor at term. Our results also suggest that the 
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chorioamniotic membranes can synthesize CASP-4 in the event of infection, where Gram-
negative bacteria may cause non-canonical activation of inflammasomes.  
 
Increased mRNA abundance and protein concentration of IL-1β in the chorioamniotic 
membranes in spontaneous labor at term 
The produced active forms of CASP-1 (p10 and p20) assemble to form hetero-tetramers 
that convert inactive pro-IL-1β into its bioactive and secreted form.113, 224-230 Therefore, we 
investigated whether the chorioamniotic membranes express IL1B and release its bioactive form. 
We found that the mRNA abundance and release of the pro- and mature forms of IL-1β were 
higher in the chorioamniotic membranes from women who had undergone spontaneous labor at 
term than in those without labor. Elevated amniotic fluid IL-1β in spontaneous labor at term was 
demonstrated more than two decades ago.7-9 IL-1β actively participates in the process of labor by 
inducing: 1) the biosynthesis of prostaglandin E2 by the human amnion231 and myometrial 
cells232, 233, 2) the expression of cyclooxygenase-2 in human myometrial cells,234 and 3) the 
expression of matrix-metabolizing enzymes (MMP-1, -3, -9, and cathepsin S) in human cervical 
smooth muscle cells.235 Indeed, systemic administration of IL-1β causes preterm birth in mice10, 
236
 and monkeys,237-244 confirming a central role for IL-1β in the process of labor, and this effect 
can be abrogated by the administration of the IL-1 receptor antagonist.10 In the study herein, we 
demonstrated that the chorioamniotic membranes release mature IL-1β, which is most likely 
mediated by active CASP-1. This mature form of IL-1β will then participate in the physiological 
process of spontaneous labor at term.  
 
mRNA abundance and protein concentration of IL-18 in the chorioamniotic membranes do 
not increase in spontaneous labor at term 
In addition to cleaving IL-1β, active CASP-1 converts pro-IL-18 into its mature form.115-
118, 124
 Yet, contrary to IL-1β, IL-18 concentration in the amniotic fluid does not significantly 
increase during term and preterm parturition.173 This is consistent with our results since no 
increase was observed in the concentration of IL-18 in the chorioamniotic membrane extracts 
from women who underwent spontaneous labor at term when compared to those women without 
labor. Indeed, the mRNA abundance of IL-18 was lower in the chorioamniotic membranes from 
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women who underwent labor than in those without labor, and the mature form of IL-18 was 
observed mainly in non-laboring tissues at term. IL-18 is a major IFN-γ inducing factor that 
activates Th-1 responses in T cells and NK cells,245-252 and its concentration in the amniotic fluid 
increased in response to intra-amniotic infection.173, 253 It is possible that IL-18 participates in 
host defense against pathogens in the chorioamniotic membranes rather than in the physiologic 
inflammatory process of spontaneous labor at term.  
In summary, 
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FIGURE LEGENDS 
Figure 1. Inflammasome components and NOD2 protein in the chorioamniotic membranes. 
(A) mRNA abundance of inflammasome components and NOD2 protein in the chorioamniotic 
membranes from women at term with (TIL, n=28) or without labor (TNL, n=29). Relative gene 
expressions are presented as -∆Ct values. (B) Protein concentrations of inflammasome 
components and NOD2 in chorioamniotic membrane tissue lysates (n=10 each). (C) 
Representative immunostainings for inflammasome components and NOD2 in the 
chorioamniotic membranes (n=10 each), 200× magnification.  
 
Figure 2. NOD1 and NLRC4 in the chorioamniotic membranes. (A and D) mRNA 
abundance of NOD1 and NLRC4 in the chorioamniotic membranes from women at term with 
(TIL, n=28) or without labor (TNL, n=29). Relative gene expressions are presented as -∆Ct 
values. (B and E) Protein quantity of NOD1 and NLRC4 in chorioamniotic membrane tissue 
lysates (n=8 each). (C and F) Intensity of the immunostainings for NOD1 and NLRC4 in the 
chorioamniotic membranes (n=10 each) and representative immunostainings, 200× 
magnification.  
 
Figure 3. Inflammatory caspases in the chorioamniotic membranes. (A) mRNA abundance 
of CASP-1 and CASP-4 in the chorioamniotic membranes from women at term with (TIL, n=28) 
or without labor (TNL, n=29). Relative gene expressions are presented as -∆Ct values. (B) 
Protein concentrations of CASP-1 and CASP-4 in chorioamniotic membrane tissue lysates (n=10 
each). (C) Intensity of the immunostainings for CASP-1 and CASP-4 in the chorioamniotic 
membranes (n=10 each) and representative immunostainings, 200× magnification. (D) 
Immunoblotting of CASP-1, CASP-4, and GAPDH in the chorioamniotic membranes and their 
quantifications (n=4 each).  
 
Figure 4. IL-1β in the chorioamniotic membranes. (A) mRNA abundance of IL1β in the 
chorioamniotic membranes from women at term with (TIL, n=28) or without labor (TNL, n=29). 
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Relative gene expressions are presented as -∆Ct values. (B) Protein concentrations of mature and 
pro-form IL-1β in chorioamniotic membrane supernatants (TNL, n=7, and TIL, n=4). (C) 
Intensity of the immunostainings for IL-1β in the chorioamniotic membranes (n=10 each) and 
representative immunostainings, 200× magnification.  
 
Figure 5. IL-18 in the chorioamniotic membranes. (A) mRNA abundance of IL-18 in the 
chorioamniotic membranes from women at term with (TIL, n=28) or without labor (TNL, n=29). 
Relative gene expressions are presented as -∆Ct values. (B) Protein concentrations of IL-18 in 
chorioamniotic membrane tissue lysates (n=10 each). (C) Intensity of the immunostainings for 
IL-18 in the chorioamniotic membranes (n=10 each) and representative immunostainings, 200× 
magnification. (D) Immunoblotting of IL-18 and GAPDH in the chorioamniotic membranes (n=4 
each).  
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Table I. Demographic and clinical characteristics of the study populations 
  TNL  TIL P value  
  (n=29) (n=28) 
Maternal age (years)* 24.0 (19-35.0) 21.5 (16.0-31.0) 0.01 
Race**     
NS 
     African-American  25 (89.3%) 24 (88.9%) 
     Caucasian  1 (3.6%) 2 (7.4%) 
     Hispanic  1 (3.6%) 0 (0.0%) 
     Other 1 (3.6%) 1 (3.7%) 
Maternal weight (kg)* 86 (44-136) 66 (49-109) 0.0002 
Body mass index (kg/m²)* 33.9 (19.80-48.40) 24.5 (18.30-41.20) 0.001 
Gestational age at delivery (weeks)* 39.4 (37.1-40.9) 39.7 (37.1-41.7) NS 
Birth weight (grams)* 3385 (2960-4010) 3270 (2750-3870) NS 
Cesarean section** 100% 32.1% 0.01 
Acute chorioamnionitis 0% 0% NA 
 
*Mann-Whitney test 
**Chi-square test 
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Table II. TaqMan® assays used for gene expression profiling 
 
Gene Symbol Protein Name Assay ID 
ACTB Actin beta Hs99999903_m1 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase Hs99999905_m1 
RPLP0 Ribosomal protein, large, P0  Hs99999902_m1  
NLRP1 NACHT, LRR and PYD domains-containing protein 1 Hs00248187_m1 
NLRP3 NACHT, LRR and PYD domains-containing protein 3 Hs00918082_m1 
NLRC4 NLR family CARD domain-containing protein 4 Hs00368367_m1 
NOD1 Nucleotide-binding oligomerization domain-containing protein 1 Hs00196075_m1 
NOD2 Nucleotide-binding oligomerization domain-containing protein 2 Hs00223394_m1 
AIM2 Absent in melanoma 2 Hs00915710_m1 
CASP1 Caspase-1 / Interleukin-1 converting enzyme Hs00354836_m1 
CASP4 Caspase-4 Hs01031947_m1 
IL1B Interleukin-1 beta Hs00174097_m1 
IL18 Interleukin-18 Hs01038788_m1 
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Table III. Primary antibodies and immunostaining conditions 
 
Primary antibody Vendor 
Host species / 
clonality Dilution 
Incubation 
time 
Anti-AIM2 Santa Cruz Biotechnology (Dallas, TX, USA) Rabbit / polyclonal (1:100) 15 min 
Anti-CARD7 (NLRP1) Acris Antibodies (Herford, Germany) Rabbit / polyclonal (1:500) 15 min 
Anti-CARD12 (NLRC4) Abcam Inc. (Cambridge, MA, USA) Rabbit / polyclonal (1:1500) 15 min 
Anti-CARD15 (NOD2) Abcam Inc. (Cambridge, MA, USA) Rabbit / polyclonal (1:200) 15 min 
Anti-CASP1 R&D Systems, Inc. (Minneapolis, MN, USA) Mouse / monoclonal (1:2000) 15 min 
Anti-CASP4 Abcam Inc. (Cambridge, MA, USA) Rabbit / polyclonal (1:100) 15 min 
Anti-CIAS/NALP3 (NLRP3) Millipore Corporation (Temecula, CA, USA) Rabbit / polyclonal (1:100) 15 min 
Anti-NOD1 Lifespan Bio (Seattle, WA, USA) Rabbit / polyclonal (1:200) 15 min 
IL-1β Novus Biologicals (Littleton, CO, USA) Rabbit / polyclonal (1:50) 15 min 
IL-18 Lifespan Bio (Seattle, WA, USA) Rabbit / polyclonal (1:10) 15 min 
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